Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2004-4-16
pubmed:abstractText
A high plasma homocysteine concentration is an independent risk factor for large and possibly small vessel disease. We investigated the effects of homocysteine-lowering treatment with folic acid plus vitamin B(6) on markers of cerebrovascular atherosclerosis and cerebral microangiopathy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0014-2972
pubmed:author
pubmed:issnType
Print
pubmed:volume
34
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
256-61
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15086356-Adult, pubmed-meshheading:15086356-Arteriosclerosis, pubmed-meshheading:15086356-Biological Markers, pubmed-meshheading:15086356-Cerebrovascular Circulation, pubmed-meshheading:15086356-Cross-Over Studies, pubmed-meshheading:15086356-Drug Therapy, Combination, pubmed-meshheading:15086356-Female, pubmed-meshheading:15086356-Folic Acid, pubmed-meshheading:15086356-Hematinics, pubmed-meshheading:15086356-Homocysteine, pubmed-meshheading:15086356-Humans, pubmed-meshheading:15086356-Magnetic Resonance Angiography, pubmed-meshheading:15086356-Magnetic Resonance Imaging, pubmed-meshheading:15086356-Male, pubmed-meshheading:15086356-Middle Aged, pubmed-meshheading:15086356-Risk Factors, pubmed-meshheading:15086356-Treatment Outcome, pubmed-meshheading:15086356-Vitamin B 6
pubmed:year
2004
pubmed:articleTitle
Effect of homocysteine-lowering treatment with folic acid plus vitamin B on cerebrovascular atherosclerosis and white matter abnormalities as determined by MRA and MRI: a placebo-controlled, randomized trial.
pubmed:affiliation
'Vrije Universiteit' Medical Center (VUMC), Institute for Cardiovascular Research (IcaR-VU), Amserdam, the Netherlands. EJG.Vermeulen@gelre.nl
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't